Offer new treatments only as part of post-market trials until data on meaningful outcomes are available, says Ben Goldacre to BMJ

Watch the video from the BMJ channel below:

Comments

Popular posts from this blog

Top medicine articles for November 2014

Neurological center at Cleveland Clinic Florida: Egil and Pauline Braathen Center